Amarin’s Vascepa prevents second and third heart attacks in analysis, fueling debate

 A new analysis of a large study unveiled last November shows that Vascepa, a fish-oil-derived drug sold by Amarin Pharmaceuticals, reduces second and third heart attacks as well as first ones.